Fundraising Fox

RETHAM TECHNOLOGIES LLC

Wauwatosa, US · Founded 2024

Retham Technologies develops diagnostic assays for heparin-induced thrombocytopenia (HIT) and related blood disorders. The company serves clinical laboratories and healthcare systems with in vitro diagnostic tests.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

SV
Steven VisuriPresident & CEO
AP
Anand PadmanabhanChief Science Officer
VS
Visuri StevenExecutive

Board

CJ
Curtis JonesBoard director

Reported raises · per SEC filings

Form D private placements

$1.1M disclosed across 1 round · 2026

▶$1.1MraisedSep 2026 · 6 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Visuri StevenExecutive Officer, Director
  • Curtis JonesDirector
  • Anand PadmanabhanDirector
Offering amount
$1.5M
Amount sold
$1.1M
First sale
Aug 2026
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase I2019$224.7K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does RETHAM TECHNOLOGIES LLC do?
Retham Technologies develops diagnostic assays for heparin-induced thrombocytopenia (HIT) and related blood disorders. The company serves clinical laboratories and healthcare systems with in vitro diagnostic tests.
How much funding has RETHAM TECHNOLOGIES LLC raised?
RETHAM TECHNOLOGIES LLC has disclosed $1.1M raised across 1 round.
Where is RETHAM TECHNOLOGIES LLC headquartered?
RETHAM TECHNOLOGIES LLC is headquartered in Wauwatosa, US.